For instance, it has been shown that higher levels of IL‐1β in younger ages (4 to 17 years‐old) were associated with future risk of rheumatoid arthritis, inflammatory bowel disease, and osteopenia in adults (Pascual et al. 2005). Here, IL1B is linked to inflammatory bowel disease.